Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Breast Neoplasms × tocilizumab × Clear all

Phase

Status

Terminated 2 Completed 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 4 Recurrence 3 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Ovarian Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Cytokine Release Syndrome 1 Craniopharyngioma 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Advanced Liver Cancers 1

Interventions

Fulvestrant 49 Letrozole 38 Trastuzumab 37 pembrolizumab 36 Capecitabine 35 ribociclib 32 Cyclophosphamide 31 abemaciclib 30 Specimen Handling 27 Paclitaxel 27 Carboplatin 27 trastuzumab deruxtecan 25 pertuzumab 24 Blood Specimen Collection 24 Surveys and Questionnaires 22 Docetaxel 22 Magnetic Resonance Spectroscopy 20 Tamoxifen 19 Anastrozole 19 Radiotherapy 18 Biopsy 18 sacituzumab govitecan 17 palbociclib 17 exemestane 17 Injections 17 130-nm albumin-bound paclitaxel 16 Neoadjuvant Therapy 14 Bevacizumab 14 olaparib 13 Standard of Care 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03424005 2026-03-16

Morpheus-panBC

Hoffmann-La Roche

Phase 1/2 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡